ArticleCancer science2019

Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.

Yuki Kiyozumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.